Emily Mason-Osann Receives PhRMA Foundation Pre Doctoral Fellowship
Emily Mason-Osann, a fourth year Ph.D. student in the Program in Biomolecular Pharmacology, has received a pre doctoral fellowship in pharmacology/toxicology from the PhRMA Foundation. The research proposed is titled, “Defining Mechanism and Therapeutic Targets in the Alternative Lengthening of the Telomeres Pathway.” She is pursuing her thesis research under the mentorship of Rachel L. Flynn, Ph.D., Assistant Professor of Pharmacology and Medicine, in the Laboratory of Genomic Stability and Cancer Therapeutics.
The award announcement was made at the 2019 Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics in Orlando on April 10, 2019. This award provides $20,000 per year for up to two years for PhD candidates who have completed most of their pre-thesis requirements and are engaged in their thesis research.
Congratulations Emily!